Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Bone Diseases × Denosumab × Clear all

Phase

Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Giant Cell Tumor of Bone 2 Breast Neoplasms 2 Osteoporotic Fractures 1 Osteoporosis 1 Musculoskeletal Pain 1 Bone Diseases 1 Arthralgia 1

Interventions

Pamidronate 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02101164 2015-02-18

Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

Amgen

Phase 4 Withdrawn

Bone Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡